- Home
- PSNL vs OPY Comparison
PSNL vs OPY Comparison
Compare PSNL & OPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNL
- OPY
- Stock Information
- Founded
- PSNL 2011
- OPY 1881
- Country
- PSNL United States
- OPY United States
- Employees
- PSNL N/A
- OPY N/A
- Industry
- PSNL Medical Specialities
- OPY Investment Bankers/Brokers/Service
- Sector
- PSNL Health Care
- OPY Finance
- Exchange
- PSNL Nasdaq
- OPY Nasdaq
- Market Cap
- PSNL 854.8M
- OPY 730.3M
- IPO Year
- PSNL 2019
- OPY N/A
- Fundamental
- Price
- PSNL $8.86
- OPY $66.97
- Analyst Decision
- PSNL Strong Buy
- OPY
- Analyst Count
- PSNL 5
- OPY 0
- Target Price
- PSNL $8.70
- OPY N/A
- AVG Volume (30 Days)
- PSNL 1.3M
- OPY 38.4K
- Earning Date
- PSNL 11-04-2025
- OPY 10-31-2025
- Dividend Yield
- PSNL N/A
- OPY 1.08%
- EPS Growth
- PSNL N/A
- OPY 16.17
- EPS
- PSNL N/A
- OPY 7.46
- Revenue
- PSNL $80,317,000.00
- OPY $1,453,063,000.00
- Revenue This Year
- PSNL N/A
- OPY N/A
- Revenue Next Year
- PSNL $29.83
- OPY N/A
- P/E Ratio
- PSNL N/A
- OPY $8.99
- Revenue Growth
- PSNL 0.36
- OPY 13.48
- 52 Week Low
- PSNL $2.83
- OPY $49.26
- 52 Week High
- PSNL $10.95
- OPY $79.99
- Technical
- Relative Strength Index (RSI)
- PSNL 52.03
- OPY 38.83
- Support Level
- PSNL $9.40
- OPY $66.03
- Resistance Level
- PSNL $10.06
- OPY $75.12
- Average True Range (ATR)
- PSNL 0.89
- OPY 2.33
- MACD
- PSNL -0.18
- OPY 0.02
- Stochastic Oscillator
- PSNL 10.20
- OPY 10.34
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About OPY Oppenheimer Holdings Inc. (DE)
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.